Health ❯ Chronic Diseases ❯ Obesity

Diabetes

Heart Disease Hypertension Dietary Impact Cardiovascular Diseases Treatment Options Dietary Risks Health Risks Prevention Strategies Comorbidities Cardiovascular Disease Mental Health Spain Healthcare Challenges Healthcare Costs Treatment Efficacy Weight Management Cardiometabolic Outcomes Sugar Consumption Metabolic Health Diabetes Mellitus Type 2 Mental Health Challenges Cardiovascular Health Health Promotion Health Complications Nutrition Public Health Initiatives Public Health Crisis Cancer Health Management Insulin Sensitivity Dietary Management Dietary Interventions Medication Access

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

The pact taps an AI-enabled gut-on-a-chip platform to turn injectable peptides into pills in a crowded GLP-1 market.

Louisiana Begins SNAP Ban on Soda, Energy Drinks and Candy

Experts Flag Nutrition Risks With GLP-1 Weight-Loss Drugs

Study Finds Most U.S. Baby Foods Are Ultra-Processed, Packed With Additives and More Sugar

Year-Long, Very-High-Fat Keto Diet Triggers Metabolic Harm in Mice

Irisin-Like Proteins From Gut Bacteria Enter First Human Trials

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months